Histoplasmosis Diagnosis: Testing Methods and Clinical Approach

Histoplasmosis, caused by Histoplasma capsulatum (dimorphic fungus endemic in Ohio/Mississippi River valleys), requires a multimodal diagnostic strategy.

Diagnostic Modalities

1. Antigen Detection (Preferred for Acute/Disseminated)

  • Urine Histoplasma antigen (EIA): Sensitivity >90% in disseminated, ~70% in acute pulmonary. Cross-reacts with blastomycosis, coccidioidomycosis.
  • Serum/BAL antigen: Useful if urine negative.
  • Quantitative levels monitor treatment response.

2. Antibody Serology

  • Complement fixation (CF) & immunodiffusion (ID): CF titers ≥1:32 suggest active infection; rising titers confirm. ID more specific (M and H bands).
  • Less sensitive in immunocompromised; may be negative early.

3. Culture (Gold Standard)

  • Sputum, BAL, blood, bone marrow, tissue.
  • Grows at 25–30°C as mold (tuberculate macroconidia); converts to yeast at 37°C.
  • Weeks to result; biosafety level 3.

4. Histopathology

  • Tissue biopsy (lymph node, liver, marrow, lung): GMS or PAS stain shows narrow-based budding yeasts (2–4 µm) within macrophages.
  • Granulomatous inflammation typical.

5. Molecular

  • PCR (DNA probe) on culture or direct specimen: rapid, specific.
  • Not yet widely standardized for direct clinical specimens.

6. Imaging

  • CXR: diffuse reticulonodular, mediastinal adenopathy, cavities (chronic).
  • CT: tree-in-bud, nodules, "ground glass," mediastinal nodes.

Diagnostic Algorithm

  1. Clinical suspicion (exposure + symptoms).
  2. Urine/serum antigen + serology (CF/ID) simultaneously.
  3. If negative but high suspicion → bronchoscopy ± biopsy for culture/histology.
  4. Antigen quantification guides duration of therapy.

IDSA guidelines recommend itraconazole for mild/moderate; liposomal amphotericin B for severe/disseminated.

Hysterectomy - Related Articles